nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Are there fundamental deficiencies in the megatrial methodology?
|
Julian, Desmond |
|
2001 |
2 |
1 |
|
artikel |
2 |
Debate: "How low should LDL cholesterol be lowered for optimum prevention of vascular disease?" Viewpoint: "Below 100 mg/dl"
|
Brown, W Virgil |
|
2001 |
2 |
1 |
p. 12-15 |
artikel |
3 |
Debate: "How low should LDL cholesterol be lowered?" Viewpoint: "It doesn't need to be very low"
|
Fazio, Sergio |
|
2001 |
2 |
1 |
p. 8-11 |
artikel |
4 |
Experience collecting interim data on mortality: an example from the RALES study
|
Wittes, Janet |
|
2001 |
2 |
1 |
p. 59-62 |
artikel |
5 |
Fundamental deficiencies in the megatrial methodology
|
Charlton, Bruce G |
|
2001 |
2 |
1 |
p. 2-7 |
artikel |
6 |
New immunosuppressive drugs in heart transplantation
|
Costanzo, Maria Rosa |
|
2001 |
2 |
1 |
p. 45-53 |
artikel |
7 |
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial
|
Eichhorn, Eric J |
|
2001 |
2 |
1 |
p. 20-23 |
artikel |
8 |
The current status of primary prevention in coronary heart disease
|
Pater, Cornel |
|
2001 |
2 |
1 |
p. 24-37 |
artikel |
9 |
The Proliferation REduction with Vascular ENergy Trial (PREVENT)
|
Raizner, Albert E |
|
2001 |
2 |
1 |
p. 16-19 |
artikel |
10 |
Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials
|
Warach, Steven |
|
2001 |
2 |
1 |
p. 38-44 |
artikel |